RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Karl E. Klose to Humans

This is a "connection" page, showing publications Karl E. Klose has written about Humans.
Connection Strength

0.446
  1. Lloyd CJ, Guo S, Kinrade B, Zahiri H, Eves R, Ali SK, Yildiz F, Voets IK, Davies PL, Klose KE. A peptide-binding domain shared with an Antarctic bacterium facilitates Vibrio cholerae human cell binding and intestinal colonization. Proc Natl Acad Sci U S A. 2023 09 26; 120(39):e2308238120.
    View in: PubMed
    Score: 0.043
  2. Nguyen JQ, Zogaj X, Adelani AA, Chu P, Yu JJ, Arulanandam BP, Klose KE. Intratracheal Inoculation of Fischer 344 Rats with Francisella tularensis. J Vis Exp. 2017 09 30; (127).
    View in: PubMed
    Score: 0.029
  3. Sarva ST, Waldo RH, Belland RJ, Klose KE. Comparative Transcriptional Analyses of Francisella tularensis and Francisella novicida. PLoS One. 2016; 11(8):e0158631.
    View in: PubMed
    Score: 0.026
  4. Weber GG, Kortmann J, Narberhaus F, Klose KE. RNA thermometer controls temperature-dependent virulence factor expression in Vibrio cholerae. Proc Natl Acad Sci U S A. 2014 Sep 30; 111(39):14241-6.
    View in: PubMed
    Score: 0.023
  5. Zogaj X, Wyatt GC, Klose KE. Cyclic di-GMP stimulates biofilm formation and inhibits virulence of Francisella novicida. Infect Immun. 2012 Dec; 80(12):4239-47.
    View in: PubMed
    Score: 0.020
  6. Childers BM, Cao X, Weber GG, Demeler B, Hart PJ, Klose KE. N-terminal residues of the Vibrio cholerae virulence regulatory protein ToxT involved in dimerization and modulation by fatty acids. J Biol Chem. 2011 Aug 12; 286(32):28644-55.
    View in: PubMed
    Score: 0.018
  7. Weber GG, Klose KE. The complexity of ToxT-dependent transcription in Vibrio cholerae. Indian J Med Res. 2011 Feb; 133:201-6.
    View in: PubMed
    Score: 0.018
  8. Chaparro AP, Ali SK, Klose KE. The ToxT-dependent methyl-accepting chemoreceptors AcfB and TcpI contribute to Vibrio cholerae intestinal colonization. FEMS Microbiol Lett. 2010 Jan; 302(2):99-105.
    View in: PubMed
    Score: 0.017
  9. Syed KA, Beyhan S, Correa N, Queen J, Liu J, Peng F, Satchell KJ, Yildiz F, Klose KE. The Vibrio cholerae flagellar regulatory hierarchy controls expression of virulence factors. J Bacteriol. 2009 Nov; 191(21):6555-70.
    View in: PubMed
    Score: 0.016
  10. Zogaj X, Chakraborty S, Liu J, Thanassi DG, Klose KE. Characterization of the Francisella tularensis subsp. novicida type IV pilus. Microbiology (Reading). 2008 Jul; 154(Pt 7):2139-2150.
    View in: PubMed
    Score: 0.015
  11. Morris DC, Peng F, Barker JR, Klose KE. Lipidation of an FlrC-dependent protein is required for enhanced intestinal colonization by Vibrio cholerae. J Bacteriol. 2008 Jan; 190(1):231-9.
    View in: PubMed
    Score: 0.014
  12. Childers BM, Klose KE. Regulation of virulence in Vibrio cholerae: the ToxR regulon. Future Microbiol. 2007 Jun; 2(3):335-44.
    View in: PubMed
    Score: 0.014
  13. Lauriano CM, Ghosh C, Correa NE, Klose KE. The sodium-driven flagellar motor controls exopolysaccharide expression in Vibrio cholerae. J Bacteriol. 2004 Aug; 186(15):4864-74.
    View in: PubMed
    Score: 0.011
  14. Sherik M, Eves R, Guo S, Lloyd CJ, Klose KE, Davies PL. Sugar-binding and split domain combinations in repeats-in-toxin adhesins from Vibrio cholerae and Aeromonas veronii mediate cell-surface recognition and hemolytic activities. mBio. 2024 Feb 14; 15(2):e0229123.
    View in: PubMed
    Score: 0.011
  15. Dressler TL, Han Lee V, Klose K, Eliason EJ. Thermal tolerance and vulnerability to warming differ between populations of wild Oncorhynchus mykiss near the species' southern range limit. Sci Rep. 2023 09 04; 13(1):14538.
    View in: PubMed
    Score: 0.011
  16. Reidl J, Klose KE. Vibrio cholerae and cholera: out of the water and into the host. FEMS Microbiol Rev. 2002 Jun; 26(2):125-39.
    View in: PubMed
    Score: 0.010
  17. Klose KE. Regulation of virulence in Vibrio cholerae. Int J Med Microbiol. 2001 May; 291(2):81-8.
    View in: PubMed
    Score: 0.009
  18. Klose KE. The suckling mouse model of cholera. Trends Microbiol. 2000 Apr; 8(4):189-91.
    View in: PubMed
    Score: 0.009
  19. Provenzano D, Schuhmacher DA, Barker JL, Klose KE. The virulence regulatory protein ToxR mediates enhanced bile resistance in Vibrio cholerae and other pathogenic Vibrio species. Infect Immun. 2000 Mar; 68(3):1491-7.
    View in: PubMed
    Score: 0.008
  20. Correa NE, Lauriano CM, McGee R, Klose KE. Phosphorylation of the flagellar regulatory protein FlrC is necessary for Vibrio cholerae motility and enhanced colonization. Mol Microbiol. 2000 Feb; 35(4):743-55.
    View in: PubMed
    Score: 0.008
  21. Schuhmacher DA, Klose KE. Environmental signals modulate ToxT-dependent virulence factor expression in Vibrio cholerae. J Bacteriol. 1999 Mar; 181(5):1508-14.
    View in: PubMed
    Score: 0.008
  22. Klose KE, Mekalanos JJ. Distinct roles of an alternative sigma factor during both free-swimming and colonizing phases of the Vibrio cholerae pathogenic cycle. Mol Microbiol. 1998 May; 28(3):501-20.
    View in: PubMed
    Score: 0.007
  23. Protz K, Reich-Schupke S, Klose K, Augustin M, Heyer K. [Compression devices for decongestion therapy : A?cross-sectional observational survey of handling, pressure, and comfort]. Hautarzt. 2018 Mar; 69(3):232-241.
    View in: PubMed
    Score: 0.007
  24. Gutknecht M, Herberger K, Klose K, Purwins S, Dietz D, Blome C, Augustin M. Cost-of-illness of patients with lymphoedema. J Eur Acad Dermatol Venereol. 2017 Nov; 31(11):1930-1935.
    View in: PubMed
    Score: 0.007
  25. Mazel D, Colwell R, Klose K, Oliver J, Crumlish M, McDougald D, Bland MJ, Austin B. VIBRIO 2014 meeting report. Res Microbiol. 2014 Dec; 165(10):857-64.
    View in: PubMed
    Score: 0.006
  26. Cunningham AL, Dang KM, Yu JJ, Guentzel MN, Heidner HW, Klose KE, Arulanandam BP. Enhancement of vaccine efficacy by expression of a TLR5 ligand in the defined live attenuated Francisella tularensis subsp. novicida strain U112?iglB::fljB. Vaccine. 2014 Sep 08; 32(40):5234-40.
    View in: PubMed
    Score: 0.006
  27. Signarovitz AL, Ray HJ, Yu JJ, Guentzel MN, Chambers JP, Klose KE, Arulanandam BP. Mucosal immunization with live attenuated Francisella novicida U112?iglB protects against pulmonary F. tularensis SCHU S4 in the Fischer 344 rat model. PLoS One. 2012; 7(10):e47639.
    View in: PubMed
    Score: 0.005
  28. Hankins JV, Madsen JA, Giles DK, Childers BM, Klose KE, Brodbelt JS, Trent MS. Elucidation of a novel Vibrio cholerae lipid A secondary hydroxy-acyltransferase and its role in innate immune recognition. Mol Microbiol. 2011 Sep; 81(5):1313-29.
    View in: PubMed
    Score: 0.005
  29. Murthy AK, Chaganty BK, Troutman T, Guentzel MN, Yu JJ, Ali SK, Lauriano CM, Chambers JP, Klose KE, Arulanandam BP. Mannose-containing oligosaccharides of non-specific human secretory immunoglobulin A mediate inhibition of Vibrio cholerae biofilm formation. PLoS One. 2011 Feb 09; 6(2):e16847.
    View in: PubMed
    Score: 0.005
  30. Thompson FL, Thompson CC, Vicente AC, Klose KE. Vibrio2009: the third international conference on the biology of Vibrios. Mol Microbiol. 2010 Sep; 77(5):1065-71.
    View in: PubMed
    Score: 0.004
  31. Fong JCN, Syed KA, Klose KE, Yildiz FH. Role of Vibrio polysaccharide (vps) genes in VPS production, biofilm formation and Vibrio cholerae pathogenesis. Microbiology (Reading). 2010 Sep; 156(Pt 9):2757-2769.
    View in: PubMed
    Score: 0.004
  32. Ray HJ, Chu P, Wu TH, Lyons CR, Murthy AK, Guentzel MN, Klose KE, Arulanandam BP. The Fischer 344 rat reflects human susceptibility to francisella pulmonary challenge and provides a new platform for virulence and protection studies. PLoS One. 2010 Apr 01; 5(4):e9952.
    View in: PubMed
    Score: 0.004
  33. Yu JJ, Goluguri T, Guentzel MN, Chambers JP, Murthy AK, Klose KE, Forsthuber TG, Arulanandam BP. Francisella tularensis T-cell antigen identification using humanized HLA-DR4 transgenic mice. Clin Vaccine Immunol. 2010 Feb; 17(2):215-22.
    View in: PubMed
    Score: 0.004
  34. Chatterjee S, Ghosh K, Raychoudhuri A, Chowdhury G, Bhattacharya MK, Mukhopadhyay AK, Ramamurthy T, Bhattacharya SK, Klose KE, Nandy RK. Incidence, virulence factors, and clonality among clinical strains of non-O1, non-O139 Vibrio cholerae isolates from hospitalized diarrheal patients in Kolkata, India. J Clin Microbiol. 2009 Apr; 47(4):1087-95.
    View in: PubMed
    Score: 0.004
  35. Mohapatra NP, Soni S, Reilly TJ, Liu J, Klose KE, Gunn JS. Combined deletion of four Francisella novicida acid phosphatases attenuates virulence and macrophage vacuolar escape. Infect Immun. 2008 Aug; 76(8):3690-9.
    View in: PubMed
    Score: 0.004
  36. Santic M, Molmeret M, Barker JR, Klose KE, Dekanic A, Doric M, Abu Kwaik Y. A Francisella tularensis pathogenicity island protein essential for bacterial proliferation within the host cell cytosol. Cell Microbiol. 2007 Oct; 9(10):2391-403.
    View in: PubMed
    Score: 0.003
  37. Xicohtencatl-Cort?s J, Lyons S, Chaparro AP, Hern?ndez DR, Salda?a Z, Ledesma MA, Rend?n MA, Gewirtz AT, Klose KE, Gir?n JA. Identification of proinflammatory flagellin proteins in supernatants of Vibrio cholerae O1 by proteomics analysis. Mol Cell Proteomics. 2006 Dec; 5(12):2374-83.
    View in: PubMed
    Score: 0.003
  38. Thompson FL, Klose KE. Vibrio2005: the First International Conference on the Biology of Vibrios. J Bacteriol. 2006 Jul; 188(13):4592-6.
    View in: PubMed
    Score: 0.003
  39. Santic M, Molmeret M, Klose KE, Abu Kwaik Y. Francisella tularensis travels a novel, twisted road within macrophages. Trends Microbiol. 2006 Jan; 14(1):37-44.
    View in: PubMed
    Score: 0.003
  40. Schild S, Lamprecht AK, Fourestier C, Lauriano CM, Klose KE, Reidl J. Characterizing lipopolysaccharide and core lipid A mutant O1 and O139 Vibrio cholerae strains for adherence properties on mucus-producing cell line HT29-Rev MTX and virulence in mice. Int J Med Microbiol. 2005 Aug; 295(4):243-51.
    View in: PubMed
    Score: 0.003
  41. Santic M, Molmeret M, Klose KE, Jones S, Kwaik YA. The Francisella tularensis pathogenicity island protein IglC and its regulator MglA are essential for modulating phagosome biogenesis and subsequent bacterial escape into the cytoplasm. Cell Microbiol. 2005 Jul; 7(7):969-79.
    View in: PubMed
    Score: 0.003
  42. Kern WV, Klose K, Jellen-Ritter AS, Oethinger M, Bohnert J, Kern P, Reuter S, von Baum H, Marre R. Fluoroquinolone resistance of Escherichia coli at a cancer center: epidemiologic evolution and effects of discontinuing prophylactic fluoroquinolone use in neutropenic patients with leukemia. Eur J Clin Microbiol Infect Dis. 2005 Feb; 24(2):111-8.
    View in: PubMed
    Score: 0.003
  43. Hassett DJ, Limbach PA, Hennigan RF, Klose KE, Hancock RE, Platt MD, Hunt DF. Bacterial biofilms of importance to medicine and bioterrorism: proteomic techniques to identify novel vaccine components and drug targets. Expert Opin Biol Ther. 2003 Dec; 3(8):1201-7.
    View in: PubMed
    Score: 0.003
  44. Nesper J, Kraiss A, Schild S, Blass J, Klose KE, Bockem?hl J, Reidl J. Comparative and genetic analyses of the putative Vibrio cholerae lipopolysaccharide core oligosaccharide biosynthesis (wav) gene cluster. Infect Immun. 2002 May; 70(5):2419-33.
    View in: PubMed
    Score: 0.002
  45. Watnick PI, Lauriano CM, Klose KE, Croal L, Kolter R. The absence of a flagellum leads to altered colony morphology, biofilm development and virulence in Vibrio cholerae O139. Mol Microbiol. 2001 Jan; 39(2):223-35.
    View in: PubMed
    Score: 0.002
  46. Nesper J, Kapfhammer D, Klose KE, Merkert H, Reidl J. Characterization of vibrio cholerae O1 antigen as the bacteriophage K139 receptor and identification of IS1004 insertions aborting O1 antigen biosynthesis. J Bacteriol. 2000 Sep; 182(18):5097-104.
    View in: PubMed
    Score: 0.002
  47. Altwein JE, Schreiter F, Klose K. [Septic complications of obstructive ureteral stones]. Helv Chir Acta. 1974; 41(3):395-9.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support